Literature DB >> 2684524

Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease.

P Scigalla1, K E Bonzel, M Bulla, R Burghard, J Dippel, J Geisert, E Leumann, T von Lilien, D E Müller-Wiefel, G Offner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2684524     DOI： 10.1159/000417899

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  9 in total

1.  One year's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis.

Authors:  G Offner; P F Hoyer; K Latta; L Winkler; J Brodehl; P Scigalla
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Effect of recombinant human erythropoietin (rHuEPO) on protein, zinc (Zn), nickel (Ni) and manganese (Mn) in patients undergoing chronic haemodialysis.

Authors:  S Hosokawa; O Yoshida
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association.

Authors:  J R Burke
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

4.  Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis.

Authors:  R E Reddingius; C H Schröder; L A Monnens
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

5.  Epoetin alfa in anaemic children or adolescents on regular dialysis.

Authors:  M G Bianchetti; I Hämmerli; C Roduit; T J Neuhaus; E P Leumann; O H Oetliker
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

6.  The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.

Authors:  S Túri; I Németh; I Varga; T Bodrogi; B Matkovics
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

7.  Recombinant erythropoietin (Epogen) improves cardiac exercise performance in children with end-stage renal disease.

Authors:  G R Martin; J R Ongkingo; M E Turner; E S Skurow; E J Ruley
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

Review 8.  Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review.

Authors:  Gordon Bruce; Peter Schulga; Ben C Reynolds
Journal:  Clin Kidney J       Date:  2022-02-26

Review 9.  The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.

Authors:  Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2003-05-15       Impact factor: 3.714
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.